Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 7142370, 27 pages
https://doi.org/10.1155/2017/7142370
Review Article

A Review on the Medicinal Plant Dalbergia odorifera Species: Phytochemistry and Biological Activity

Department of Bioactive Products, Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Cau Giay, Hanoi, Vietnam

Correspondence should be addressed to Son Ninh The; moc.liamg@nostnamay

Received 16 August 2017; Accepted 25 October 2017; Published 4 December 2017

Academic Editor: Vincenzo De Feo

Copyright © 2017 Son Ninh The. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. W. L. Zheng, X. Guo, X. Li, and Z. Chen, “Essential oil composition from the seeds of Dalbergia odorifera T. Chen grown in Hainan, China,” Journal of Food, Agriculture & Environment, vol. 9, pp. 26–28, 2011. View at Google Scholar
  2. S. Sun, X. Zeng, D. Zhang, and S. Guo, “Diverse fungi associated with partial irregular heartwood of Dalbergia odorifera,” Scientific Reports, vol. 5, article 8464, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. W. Choi, Y. H. Choi, M.-R. Cha et al., “Yeast α-glucosidase inhibition by isoflavones from plants of leguminosae as an in vitro alternative to acarbose,” Journal of Agricultural and Food Chemistry, vol. 58, no. 18, pp. 9988–9993, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D.-S. Lee and G.-S. Jeong, “Arylbenzofuran isolated from Dalbergia odorifera suppresses lipopolysaccharide-induced mouse BV2 microglial cell activation, which protects mouse hippocampal HT22 cells death from neuroinflammation-mediated toxicity,” European Journal of Pharmacology, vol. 728, no. 1, pp. 1–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. D.-S. Lee, B. Li, S. Keo et al., “Inhibitory effect of 9-hydroxy-6,7-dimethoxydalbergiquinol from Dalbergia odorifera on the NF-κB-related neuroinflammatory response in lipopolysaccharide-stimulated mouse BV2 microglial cells is mediated by heme oxygenase-1,” International Immunopharmacology, vol. 17, no. 3, pp. 828–835, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Li, L. Wu, W. Liu et al., “A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action,” PLoS ONE, vol. 9, no. 5, Article ID e95004, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Wang, W.-L. Mei, Y.-B. Zeng et al., “Phenolic compounds from Dalbergia odorifera,” Phytochemistry Letters, vol. 9, no. 1, pp. 168–173, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Zheng, X. Zhao, S. Wang, K. Luo, Y. Wei, and J. Zheng, “Co-administration of Dalbergia odorifera increased bioavailability of Salvia miltiorrhizae in rabbits,” American Journal of Chinese Medicine, vol. 35, no. 5, pp. 831–840, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Li, X. Xu, X. Wang et al., “A systems biology approach to understanding the mechanisms of action of Chinese herbs for treatment of cardiovascular disease,” International Journal of Molecular Sciences, vol. 13, no. 10, pp. 13501–13520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Chen, Q. Li, C. Pan et al., “QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode,” Scientific Reports, vol. 5, no. 1, 2015. View at Publisher · View at Google Scholar
  11. A. Sugiyama, B.-M. Zhu, A. Takahara, Y. Satoh, and K. Hashimoto, “Cardiac effects of Salvia miltiorrhiza/Dalbergia odorifera mixture, an intravenously applicable Chinese medicine widely used for patients with ischemic heart disease in China,” Circulation Journal, vol. 66, no. 2, pp. 182–184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Saha, H. Mondal, F. Hossain, M. Anisuzzman, M. M. Hasan, and G. A. Cordell, “Ethnomedicinal, phytochemical, and pharmacological profile of the genus Dalbergia L. (Fabaceae),” Phytopharmacology, vol. 4, pp. 291–346, 2013. View at Google Scholar
  13. Dalbergia, 2011, http://www.theplantlist.org/search/.
  14. F.-Y. Ma, C.-B. Gu, C.-Y. Li et al., “Microwave-assisted aqueous two-phase extraction of isoflavonoids from Dalbergia odorifera T. Chen leaves,” Separation and Purification Technology, vol. 115, pp. 136–144, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. B.-Z. Hao and J.-L. Wu, “Vacuole proteins in parenchyma cells of secondary phloem and xylem of Dalbergia odorifera,” Trees - Structure and Function, vol. 8, no. 2, pp. 104–109, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Liu, D. Xu, Z. Yang, and N. Zhang, “Geographic variations in seed germination of Dalbergia odorifera T. Chen in response to temperature,” Industrial Crops and Products, vol. 102, pp. 45–50, 2017. View at Publisher · View at Google Scholar · View at Scopus
  17. J. K. Lu, X. H. He, L. B. Huang, L. H. Kang, and D. P. Xu, “Two Burkholderia strains from nodules of Dalbergia odorifera T. Chen in Hainan Island, southern China,” New Forests, vol. 43, no. 4, pp. 397–409, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S.-C. Chan, Y.-S. Chang, J.-P. Wang, S.-C. Chen, and S.-C. Kuo, “Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera,” Planta Medica, vol. 64, no. 2, pp. 153–158, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Wang, X. Weng, and D. Cheng, “Antioxidant activities of natural phenolic components from Dalbergia odorifera T. Chen,” Food Chemistry, vol. 71, no. 1, pp. 45–49, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Yahara, T. Ogata, N. Nohara et al., “Isoflavan and Related Compounds from Dalbergia odorifera. I,” Chemical & Pharmaceutical Bulletin, vol. 37, no. 4, pp. 979–987, 1989. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Goda, M. Katayama, K. Ichikawa, M. Shibuya, F. Kiuchi, and U. Sankawa, “Inhibitors of prostaglandin biosynthesis from dalbergia odorifera,” Chemical & Pharmaceutical Bulletin, vol. 33, no. 12, pp. 5606–5609, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Goda, F. Kiuchi, M. Shibuya, and U. Sankawa, “Inhibitors of prostaglandin biosynthesis from Dalbergia odorifera,” Chemical & Pharmaceutical Bulletin, vol. 40, no. 9, pp. 2452–2457, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. C. W. Choi, Y. H. Choi, M. R. Cha et al., “Antitumor components isolated from the heartwood extract of Dalbergia odorifera,” Journal of The Korean Society for Applied Biological Chemistry, vol. 52, pp. 375–379, 2009. View at Google Scholar
  24. C. Lee, J. W. Lee, Q. Jin et al., “Inhibitory constituents of the heartwood of Dalbergia odorifera on nitric oxide production in RAW 264.7 macrophages,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 14, pp. 4263–4266, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Yu, W. Wang, and M. Yang, “Antioxidant activities of compounds isolated from Dalbergia odorifera T. Chen and their inhibition effects on the decrease of glutathione level of rat lens induced by UV irradiation,” Food Chemistry, vol. 104, no. 2, pp. 715–720, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Islam, “Secondary Metabolites from Nonhost Plants Affect the Motility and Viability of Phytopathogenic Aphanomyces cochlioides Zoospores,” Zeitschrift für Naturforschung C, vol. 63, no. 3-4, 2008. View at Publisher · View at Google Scholar
  27. J. Feng, Y. Xiao, Z. Guo, D. Yu, Y. Jin, and X. Liang, “Purification of compounds from Lignum Dalbergia Odorifera using two-dimensional preparative chromatography with Click oligo (ethylene glycol) and C18 column,” Journal of Separation Science, vol. 34, no. 3, pp. 299–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. R.-B. An, G.-S. Jeong, and Y.-C. Kim, “Flavonoids from the heartwood of Dalbergia odorifera and their protective effect on glutamate-induced oxidative injury in HT22 cells,” Chemical & Pharmaceutical Bulletin, vol. 56, no. 12, pp. 1722–1724, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Zhao, Y. Liu, D. Cong et al., “Screening and determination for potential α-glucosidase inhibitory constituents from Dalbergia odorifera T. Chen using ultrafiltration-LC/ESI-MSn,” Biomedical Chromatography, vol. 27, no. 12, pp. 1621–1629, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Xu, H. Shi, T. Liang et al., “Selective separation of flavonoid glycosides in Dalbergia odorifera by matrix solid-phase dispersion using titania,” Journal of Separation Science, vol. 34, no. 11, pp. 1347–1354, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Li, J.-Z. Liu, M. Luo et al., “Efficient extraction and preparative separation of four main isoflavonoids from Dalbergia odorifera T. Chen leaves by deep eutectic solvents-based negative pressure cavitation extraction followed by macroporous resin column chromatography,” Journal of Chromatography B, vol. 1033-1034, pp. 40–48, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. F.-Y. Ma, M. Luo, C.-J. Zhao et al., “Simple and efficient preparation of biochanin A and genistein from Dalbergia odorifera T. Chen leaves using macroporous resin followed by flash chromatography,” Separation and Purification Technology, vol. 120, pp. 310–318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J.-P. Hou, H. Wu, C.-T. Ho, and X.-C. Weng, “Antioxidant activity of polyphenolic compounds from Dalbergia odorifera T. Chen,” Pakistan Journal of Nutrition, vol. 10, no. 7, pp. 694–701, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Zhao, W. Mei, M. Gong, W. Zuo, H. Bai, and H. Dai, “Antibacterial activity of the flavonoids from Dalbergia odorifera on Ralstonia solanacearum,” Molecules, vol. 16, no. 12, pp. 9775–9782, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Wang, W.-H. Dong, W.-J. Zuo et al., “Three new phenolic compounds from Dalbergia odorifera,” Journal of Asian Natural Products Research, vol. 16, no. 12, pp. 1109–1118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. S.-C. Chan, Y.-S. Chang, and S.-C. Kuo, “Neoflavonoids from Dalbergia odorifera,” Phytochemistry, vol. 46, no. 5, pp. 947–949, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. D.-S. Lee, K.-S. Kim, W. Ko et al., “The neoflavonoid latifolin isolated from meoh extract of Dalbergia odorifera attenuates inflammatory responses by inhibiting NF-κB activation via Nrf2-mediated heme oxygenase-1 expression,” Phytotherapy Research, vol. 28, no. 8, pp. 1216–1223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. H.-M. Yun, K.-R. Park, T. H. Quang et al., “2,4,5-Trimethoxyldalbergiquinol promotes osteoblastic differentiation and mineralization via the BMP and Wnt/β-catenin pathway,” Cell Death & Disease, vol. 6, no. 7, Article ID e1819, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. D. K. Miller, S. Sadowski, G. Q. Han, and H. Joshua, “Identification and isolation of medicarpin and a substituted benzofuran as potent leukotriene inhibitors in an anti-inflammatory Chinese herb,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 38, no. 2, pp. 137–143, 1989. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Ogata, S. Yahara, R. Hisatsune, R. Konishi, and T. Nohara, “Isoflavan and related compounds from Dalbergia odorifera,” Chemical and Pharmceutical Bulletin, vol. 38, pp. 2750–2755, 1990. View at Google Scholar
  41. H. Wang, W.-H. Dong, W.-J. Zuo et al., “Five new sesquiterpenoids from Dalbergia odorifera,” Fitoterapia, vol. 95, pp. 16–21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Tao and Y. Wang, “Bioactive sesquiterpenes isolated from the essential oil of Dalbergia odorifera T. Chen,” Fitoterapia, vol. 81, no. 5, pp. 393–396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Li, D.-S. Lee, G.-S. Jeong, and Y.-C. Kim, “Involvement of heme oxygenase-1 induction in the cytoprotective and immunomodulatory activities of 6,4-dihydroxy-7-methoxyflavanone in murine hippocampal and microglia cells,” European Journal of Pharmacology, vol. 674, no. 2-3, pp. 153–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. S. H. Lee, J. Y. Kim, G. S. Seo, Y.-C. Kim, and D. H. Sohn, “Isoliquiritigenin, from Dalbergia odorifera, up-regulates anti-inflammatory heme oxygenase-1 expression in RAW264.7 macrophages,” Inflammation Research, vol. 58, no. 5, pp. 257–262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. D.-S. Lee, B. Li, N.-K. Im, Y.-C. Kim, and G.-S. Jeong, “4,2,5-Trihydroxy-4-methoxychalcone from dalbergia odorifera exhibits anti-inflammatory properties by inducing heme oxygenase-1 in murine macrophages,” International Immunopharmacology, vol. 16, no. 1, pp. 114–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. Z.-J. Cheng, S.-C. Kuo, S.-C. Chan, F.-N. Ko, and C.-M. Teng, “Antioxidant properties of butein isolated from Dalbergia odorifera,” Biochimica et Biophysica Acta, vol. 1392, no. 2-3, pp. 291–299, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. S.-M. Yu, Z.-J. Cheng, and S.-C. Kuo, “Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor,” European Journal of Pharmacology, vol. 280, no. 1, pp. 69–77, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. K.-R. Park, H.-M. Yun, T.-H. Quang et al., “4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway,” Oncotarget , vol. 7, no. 6, pp. 6960–6971, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Jia, L. Chen, H.-L. Xin et al., “A friendly relationship between endophytic fungi and medicinal plants: A systematic review,” Frontiers in Microbiology, vol. 7, article no. 906, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. R.-X. Liu, L. Li, Q. Wang, W. Wang, K.-S. Bi, and D.-A. Guo, “Simultaneous determination of nine flavonoids in Dalbergia odorifera by LC,” Chromatographia, vol. 61, no. 7-8, pp. 409–413, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Liu, M. Ye, H. Guo, K. Bi, and D.-A. Guo, “Liquid chromatography/electrospray ionization mass spectrometry for the characterization of twenty-three flavonoids in the extract of Dalbergia odorifera,” Rapid Communications in Mass Spectrometry, vol. 19, no. 11, pp. 1557–1565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. S. A. Ham, E. S. Kang, T. Yoo et al., “Dalbergia odorifera Extract Ameliorates UVB-Induced Wrinkle Formation by Modulating Expression of Extracellular Matrix Proteins,” Drug Development Research, vol. 76, no. 1, pp. 48–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. H. S. Choi, J. Park, J. S. Hwang et al., “A Dalbergia odorifera extract improves the survival of endotoxemia model mice by inhibiting HMGB1 release,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  54. R. Liu, J. Sun, K. Bi, and D.-A. Guo, “Identification and determination of major flavonoids in rat serum by HPLC-UV and HPLC-MS methods following oral administration of Dalbergia odorifera extract,” Journal of Chromatography B, vol. 829, no. 1-2, pp. 35–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Zhao, Z. Guo, X. Zhang, X. Liang, and Y. Zhang, “Off-line 2-D RPLC/RPLC method for separation of components in Dalbergia odorifera T. Chen,” Journal of Separation Science, vol. 33, no. 9, pp. 1224–1230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. D.-Y. Zhang, Y.-G. Zu, Y.-J. Fu et al., “Negative pressure cavitation extraction and antioxidant activity of biochanin A and genistein from the leaves of Dalbergia odorifera T. Chen,” Separation and Purification Technology, vol. 83, no. 1, pp. 91–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. Z. Lianhe, H. Xing, and C. Zhengxing, “Antioxidant activities of seed extracts from Dalbergia odorifera T. Chen,” Afr. J. Biotechnol, vol. 10, pp. 11658–11667, 2011. View at Google Scholar
  58. Z. Lianhe, H. Xing, W. Li, and C. Zhengxing, “Physicochemical properties, chemical composition and antioxidant activity of Dalbergia odorifera T. Chen seed oil,” Journal of the American Oil Chemists’ Society, vol. 89, no. 5, pp. 883–890, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Amaral, L. Mira, J. M. F. Nogueira, A. P. D. Silva, and M. Helena Florêncio, “Plant extracts with anti-inflammatory properties-A new approach for characterization of their bioactive compounds and establishment of structure-antioxidant activity relationships,” Bioorganic & Medicinal Chemistry, vol. 17, no. 5, pp. 1876–1883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Fakhrudin, B. Waltenberger, and M. Cabaravdic, “Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo,” British Journal of Pharmacology, vol. 171, no. 7, pp. 1676–1686, 2014. View at Publisher · View at Google Scholar
  61. H. L. T. Anh, D.-C. Kim, W. Ko et al., “Anti-inflammatory coumarins from Paramignya trimera,” Pharmaceutical Biology, vol. 55, no. 1, pp. 1195–1201, 2017. View at Publisher · View at Google Scholar · View at Scopus
  62. J. P. Scott and M. Peters-Golden, “Antileukotriene agents for the treatment of lung disease,” American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 5, pp. 538–544, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. P. A. Ward, M. C. Sulavik, and K. J. Johnson, “Rat neutrophil activation and effects of lypoxygenase and cyclooxygenase inhibitors,” The American Journal of Pathology, vol. 116, no. 2, pp. 223–233, 1984. View at Google Scholar · View at Scopus
  64. C. Chen, F.-Q. Yang, Q. Zhang, F.-Q. Wang, Y.-J. Hu, and Z.-N. Xia, “Natural products for antithrombosis,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 876426, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. V. P. Stitham, L. Ying, and J. Hwa, “Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs,” Current Molecular Medicine, vol. 14, pp. 909–931, 2014. View at Google Scholar
  66. J. W. Assender, K. M. Southgate, M. B. Hallett, and A. C. Newby, “Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells,” Biochemical Journal, vol. 288, no. 2, pp. 527–532, 1992. View at Publisher · View at Google Scholar · View at Scopus
  67. V. B. Smith, D. Spina, and C. P. Page, “Phosphodiesterase inhibitors,” Bristish Journal of Pharmacology, vol. 147, pp. 252–257, 2006. View at Google Scholar
  68. N. Nishida, H. Yano, T. Nishida, T. Kamura, and M. Kojiro, “Angiogenesis in cancer,” Vascular Health and Risk Management, vol. 2, no. 3, pp. 213–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Wang, Z. Zheng, Y. Weng et al., “Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts,” Life Sciences, vol. 74, no. 20, pp. 2467–2478, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. Z. Fan, D. Wang, J. Yang et al., “Dalbergia odorifera extract promotes angiogenesis through upregulation of VEGFRs and PI3K/MAPK signaling pathways,” Journal of Ethnopharmacology, vol. 204, pp. 132–141, 2017. View at Publisher · View at Google Scholar
  71. T. Alon, I. Hemo, A. Itin, J. Pe’er, J. Stone, and E. Keshet, “Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity,” Nature Medicine, vol. 1, no. 10, pp. 1024–1028, 1995. View at Publisher · View at Google Scholar · View at Scopus
  72. R. S. Jope, C. J. Yuskaitis, and E. Beurel, “Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics,” Neurochemical Research, vol. 32, no. 4-5, pp. 577–595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. R. S. Jope and G. V. W. Johnson, “The glamour and gloom of glycogen synthase kinase-3,” Trends in Biochemical Sciences, vol. 29, no. 2, pp. 95–102, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Liu, H. Cheng, T. M. Roberts, and J. J. Zhao, “Targeting the phosphoinositide 3-kinase pathway in cancer,” Nature Reviews Drug Discovery, vol. 8, no. 8, pp. 627–644, 2009. View at Publisher · View at Google Scholar · View at Scopus